Stay updated on Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial page.

Latest updates to the Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now includes user-guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and shows that recruitment is closed ('No longer looking for participants'), along with a Revision: v3.6.0. The Intervention/Treatment heading has been reformatted from 'Intervention / Treatment'.SummaryDifference0.4%

- Check19 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a minor update to the page framework. No substantive study content or data is changed.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page now displays a new revision label 'Revision: v3.5.4', replacing the previous 'Revision: v3.5.3', indicating an updated study protocol and statistical plan document.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site/UI release rather than any change to the clinical study details.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check98 days agoChange DetectedAdded revision v3.5.0 and removed revision v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial page.